Mid-Florida Cancer Centers (MFCC) has entered into an agreement with OneOncology to enhance cancer care in central Florida.

It has been advised in this endeavour by Provident Healthcare Partners.

MFCC has become the 19th practice to join OneOncology, an expanding national platform for independent oncology practices.

It aims to improve cancer services in Central Florida, leveraging MFCC's 30 years of experience in providing personalised healthcare.

Dustin Thompson is the director in charge of Provident's deal team.

Led by Dr. Neeraj Sharma, MFCC operates in the Greater Orlando market, with four locations and a team of nine medical oncologists, two radiation oncologists, and advanced practice providers.

MFCC president Dr. Neeraj Sharma said: “It's been a pleasure working with the Provident team.

“We are grateful for the expertise and experience that they provided, their professionalism and responsive approach has ultimately culminated in our partnership with One Oncology, taking our company to the next level and ensuring continued growth.”

MFCC offers a comprehensive range of services, including oncology, haematology, radiation therapy, consultative services, infusion services, an in-house lab, oral dispensing pharmacy, and imaging services.

The latest move is expected to help MFCC further its growth by collaborating with independent oncology practices.

Thompson added: “We're excited to have had the opportunity to advise and guide Mid-Florida Cancer Centers through this transaction process.

“MFCC is a great fit as OneOncology's platform in the Central Florida market.

“The resources provided by OneOncology will help strengthen MFCC's position in the Orlando market and we wish both entities nothing but success in their partnership.”